WSTAM
FBT icon

Wilbanks Smith & Thomas Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,950
Closed -$445K – 421
2019
Q1 		$445K Buy
+2,950
New +$425K 0.03% 255

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's FBT Position: Q2 2019 in Review

Wilbanks Smith & Thomas Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2019, closing a stake of 2,950 shares — an estimated $445K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in FBT in Q1 2019 and held it in 1 quarter. The position peaked at $445K in Q1 2019. 222 funds tracked by Wall St. Rank hold FBT as of Q2 2019.

  • Wilbanks Smith & Thomas Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2019 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 2,950 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2019, an estimated $445K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $445K in Q1 2019.
  • 222 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2019.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q2 2019, filed 7 Aug 2019.